New drug HS-10518 tested for safety in healthy women
NCT ID NCT07264192
First seen Jan 05, 2026 · Last updated May 20, 2026 · Updated 21 times
Summary
This early-stage study tested the safety and tolerability of a new drug called HS-10518 in 60 healthy women aged 18-40 in China. Participants received either the drug or a placebo, and researchers monitored for side effects and how the drug moved through the body. The goal was to gather initial safety data, not to treat any condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFERTILITY, FEMALE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
West China Second University Hospital
Chengdu, China
Conditions
Explore the condition pages connected to this study.